Your browser doesn't support javascript.
loading
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Mortha, Arthur; Remark, Romain; Del Valle, Diane Marie; Chuang, Ling-Shiang; Chai, Zhi; Alves, Inês; Azevedo, Catarina; Gaifem, Joana; Martin, Jerome; Petralia, Francesca; Tuballes, Kevin; Barcessat, Vanessa; Tai, Siu Ling; Huang, Hsin-Hui; Laface, Ilaria; Jerez, Yeray Arteaga; Boschetti, Gilles; Villaverde, Nicole; Wang, Mona D; Korie, Ujunwa M; Murray, Joseph; Choung, Rok-Seon; Sato, Takahiro; Laird, Renee M; Plevy, Scott; Rahman, Adeeb; Torres, Joana; Porter, Chad; Riddle, Mark S; Kenigsberg, Ephraim; Pinho, Salomé S; Cho, Judy H; Merad, Miriam; Colombel, Jean-Frederic; Gnjatic, Sacha.
Affiliation
  • Mortha A; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Immunology, University of Toronto, Toronto, Canada.
  • Remark R; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Innate Pharma, Marseille, France.
  • Del Valle DM; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Chuang LS; Charles Bronfman Institute for Personalized Medicine, Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York
  • Chai Z; Charles Bronfman Institute for Personalized Medicine, Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York
  • Alves I; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Azevedo C; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Gaifem J; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Martin J; Université de Nantes, Inserm, CHU Nantes, Centre de Recherche en Transplantation et Immunologie, Nantes, France; CHU Nantes, Laboratoire d'Immunologie, CIMNA, Nantes, France.
  • Petralia F; Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Tuballes K; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Barcessat V; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Tai SL; Department of Immunology, University of Toronto, Toronto, Canada.
  • Huang HH; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Laface I; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Jerez YA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Boschetti G; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Hépato-Gastroentérologue, Hospices Civils de Lyon, Université Claude Bernard, Lyon, France.
  • Villaverde N; Charles Bronfman Institute for Personalized Medicine, Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Wang MD; Department of Immunology, University of Toronto, Toronto, Canada.
  • Korie UM; Charles Bronfman Institute for Personalized Medicine, Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York
  • Murray J; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Choung RS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Sato T; Janssen R&D, Spring House, Pennsylvania.
  • Laird RM; Naval Medical Research Center, Silver Spring, Maryland.
  • Plevy S; Janssen R&D, Spring House, Pennsylvania.
  • Rahman A; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Human Immune Monitoring Center at Mount Sinai, New York, New York.
  • Torres J; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York; Gastroenterology Division, Hospital Beatriz Ângelo, Loures, Portugal.
  • Porter C; Naval Medical Research Center, Silver Spring, Maryland.
  • Riddle MS; Naval Medical Research Center, Silver Spring, Maryland.
  • Kenigsberg E; Charles Bronfman Institute for Personalized Medicine, Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York; Human Immune Monitoring Center at Mount Sinai, New York, New York.
  • Pinho SS; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal; School of Medicine and Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
  • Cho JH; Charles Bronfman Institute for Personalized Medicine, Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Merad M; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Human Immune Monitoring Center at Mount Sinai, New York, New York
  • Colombel JF; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Gnjatic S; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Human Immune Monitoring Center at Mount Sinai, New York, New York
Gastroenterology ; 163(3): 659-670, 2022 09.
Article in En | MEDLINE | ID: mdl-35623454
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Ileal Diseases Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Gastroenterology Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Ileal Diseases Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Gastroenterology Year: 2022 Type: Article Affiliation country: Canada